Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas M Grabrucker

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 22, 2019
Standardization of research methods employed in assessing the interaction between metallic-based nanoparticles and the blood-brain barrier: Present and future perspectivesAisling M Ross, David Mc Nulty, Colm O'Dwyer, et al.
Nanomedicine (London, England)|January 10, 2020
Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriersJohn Je Mulvihill, Eoghan M Cunnane, Aisling M Ross, et al.
Progress in Retinal and Eye Research|September 21, 2025
Zinc in eye health, retinal biology and diseaseBrian S McKay, Andreas M Grabrucker, Richard B Thompson, et al.
Frontiers in Molecular Neuroscience|February 2, 2018
Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the BrainSimone Hagmeyer, Joana S Cristóvão, John J E Mulvihill, et al.
Pharmaceutics|January 21, 2023
Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell BarrierAisling M Ross, Rachel M Cahalane, Darragh R Walsh, et al.
Molecular Brain|March 13, 2016
Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2Tasnuva Sarowar, Stefanie Grabrucker, Karl Föhr, et al.
Frontiers in Neuroscience|July 9, 2019
Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer's Disease Model MiceSimone Hagmeyer, Mariana A Romão, Joana S Cristóvão, et al.
Frontiers in Synaptic Neuroscience|June 3, 2016
The Shank3 Interaction Partner ProSAPiP1 Regulates Postsynaptic SPAR Levels and the Maturation of Dendritic Spines in Hippocampal NeuronsDominik Reim, Tobias M Weis, Sonja Halbedl, et al.
Experimental Neurology|January 3, 2014
The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutationStefanie Grabrucker, Christian Proepper, Katharina Mangus, et al.
Plos One|March 31, 2011
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesAndreas M Grabrucker, Craig C Garner, Tobias M Boeckers, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 22, 2019
Standardization of research methods employed in assessing the interaction between metallic-based nanoparticles and the blood-brain barrier: Present and future perspectivesAisling M Ross, David Mc Nulty, Colm O'Dwyer, et al.
Nanomedicine (London, England)|January 10, 2020
Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriersJohn Je Mulvihill, Eoghan M Cunnane, Aisling M Ross, et al.
Progress in Retinal and Eye Research|September 21, 2025
Zinc in eye health, retinal biology and diseaseBrian S McKay, Andreas M Grabrucker, Richard B Thompson, et al.
Frontiers in Molecular Neuroscience|February 2, 2018
Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the BrainSimone Hagmeyer, Joana S Cristóvão, John J E Mulvihill, et al.
Pharmaceutics|January 21, 2023
Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell BarrierAisling M Ross, Rachel M Cahalane, Darragh R Walsh, et al.
Molecular Brain|March 13, 2016
Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2Tasnuva Sarowar, Stefanie Grabrucker, Karl Föhr, et al.
Frontiers in Neuroscience|July 9, 2019
Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer's Disease Model MiceSimone Hagmeyer, Mariana A Romão, Joana S Cristóvão, et al.
Frontiers in Synaptic Neuroscience|June 3, 2016
The Shank3 Interaction Partner ProSAPiP1 Regulates Postsynaptic SPAR Levels and the Maturation of Dendritic Spines in Hippocampal NeuronsDominik Reim, Tobias M Weis, Sonja Halbedl, et al.
Experimental Neurology|January 3, 2014
The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutationStefanie Grabrucker, Christian Proepper, Katharina Mangus, et al.
Plos One|March 31, 2011
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesAndreas M Grabrucker, Craig C Garner, Tobias M Boeckers, et al.
Pageof 9